Aura Biosciences Inc (AURA)
$6.14 -2.46% Close Oct 30, 2026 Live
Aura Biosciences stock today
Aura Biosciences closed at $6.14 on October 30, 2026, down 2.46% on the day. Over the past year it returned +1.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $635 million.
$6.00$8.00
NovJan 2026MarMayJulSep
| Period | AURA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -2.2% | -0.9% |
| 3 months | -13.6% | +2.1% |
| Year to date | +12.7% | +11.7% |
| 1 year | +1.0% | +12.4% |
| 3 years | -17.8% | +88.5% |
| 5 years | -58.5% | +76.0% |
Key statistics
- Market value
- $635M
- 52-week range
- $4.97 to $8.90
- Next report
- Nov 12, 2026 (estimated)
About Aura Biosciences
Aura Biosciences develops immunotherapy treatments for cancers and eye diseases.
Sector: Health Care
More on Aura Biosciences
- Returns: what $1,000 became$1,000 five years ago is $414.87 today
No forecast, no recommendation. This page describes Aura Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.